Meet Our Inventor
Samuel Achilefu, PhD
Dr. Samuel Achilefu discovered the fluorescent tumor-targeting imaging agent, LS301, and developed the novel technology behind the wearable CancerVision Goggles, which enable intraoperative visualization of LS301, in his laboratory at the Washington University School of Medicine in St. Louis. In addition to his role as Chief Scientific Officer of Integro Theranostics, Dr. Achilefu serves as the inaugural Chair of the Department of Biomedical Engineering at UT Southwestern Medical Center, where he is continuing his research. Dr. Achilefu and Integro Theranostics share the same goal in further developing and bringing these solutions to market: We strive to improve the outcome of cancer surgeries for all patients by providing real-time visual guidance to surgeons in the operating room.
Dr. Samuel Achilefu is a nationally recognized expert in molecular imaging and has demonstrated success in making a clinical impact with his innovations in this field. His seminal work in the use of fluorescent molecules for real-time cancer imaging forms the foundation for this field of research. Prior to his current role at UT Southwestern, Dr. Achilefu held a number of professorships and leadership roles during his 20 year tenure at Washington University School of Medicine, including with the Mallinckrodt Institute, the Molecular Imaging Center, and Siteman Cancer Center.
A selection of Sam Achilefu's accolades and accomplishments:
Elected to the National Academy of Medicine, one of the highest honors in the field of health and medicine, in 2021
An inventor on 65 U.S. Patents and author on over 300 published scientific papers
Appointed by the U.S. Secretary of Health and Human Services in 2020 to serve on the National Advisory Council for Biomedical Imaging and Bioengineering
Distinguished Investigator Awards from the Department of Defense Breast Cancer Research Program and the Academy for Radiology & Biomedical Imaging Research